Raised blood pressure is the leading global risk for death and causes approximately
half of cardiovascular disease (CVD) (
1
). Hence, reducing uncontrolled hypertension 25% by 2025 has become a global priority
(
1
).Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- São Paulo call to action for the prevention and control of high blood pressure: 2020.J Clin Hypertens. 2019; 21: 1744-1752
- WHO HEARTS: A global program to reduce cardiovascular disease burden: Experience implementing in the Americas and opportunities in Canada.Can J Cardiol. 2021; 37: 744-755
Campbell N YE, Adams M, Baclic O, Drouin D, Farrell J, Kaczorowski J, Lewanczuk R, Liepold H, Lum-Kwong MM, Reading J, Tone S, Allu S, Legowski B 2012;Pages. Accessed at Hypertension Canada at https://hypertension.ca/wp-content/uploads/2017/11/2012_Final_Hypertension_Framework_English.pdf on July 12 2022.
- Worsening hypertension awareness, treatment, and control rates in Canadian women between 2007 and 2017.Can J Cardiol. 2020; 36: 732-739
- Association between population hypertension control and ischemic heart disease and stroke mortality in 36 countries of the Americas, 1990-2019: an ecological study.Pan American Journal of Public Health. 2022; 46: e143
Article info
Publication history
Accepted:
March 9,
2023
Received in revised form:
February 21,
2023
Received:
January 17,
2023
Publication stage
In Press Journal Pre-ProofFootnotes
RM and PO are staff members of the Pan American Health Organization. Authors alone are responsible for the views expressed in this publication, and they do not necessarily represent those of the Pan American Health Organization.
Funding:
None
Identification
Copyright
© 2023 Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.
